| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/24/2008 | CA2675967A1 Nucleic acid constructs and methods for specific silencing of h19 |
| 07/24/2008 | CA2675964A1 H19 silencing nucleic acid agents for treating rheumatoid arthritis |
| 07/24/2008 | CA2675954A1 Methods and compositions for modulating the mirna pathway |
| 07/24/2008 | CA2675952A1 Stem cell gene targeting |
| 07/24/2008 | CA2675946A1 Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways |
| 07/24/2008 | CA2675895A1 Methods and nucleic acids for analyses of cell proliferative disorders |
| 07/24/2008 | CA2675857A1 Method and apparatus for sustaining viability of biological cells on a substrate |
| 07/24/2008 | CA2675847A1 Pegylated a.beta. fab |
| 07/24/2008 | CA2675828A1 Glycosyltransferases and polynucleotides encoding the same |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2675696A1 Plant having increased yield of seeds |
| 07/24/2008 | CA2675638A1 Novel composition for treating metabolic syndrome |
| 07/24/2008 | CA2675583A1 Inflammation treatment, detection and monitoring via trem-1 |
| 07/24/2008 | CA2675364A1 Convenient method for inhibition of gene expression using rsis |
| 07/24/2008 | CA2675192A1 In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders |
| 07/24/2008 | CA2675183A1 Apparatus and methods for osmotically shocking cells |
| 07/24/2008 | CA2675137A1 Combinatorial libraries of conformationally constrained polypeptide sequences |
| 07/24/2008 | CA2675100A1 C-reactive protein (crp) knockout mouse |
| 07/24/2008 | CA2675026A1 Compositions and methods for enhancing tolerance for the production of organic chemicals produced by microorganisms |
| 07/24/2008 | CA2674804A1 Method of making maize plants containing unique allele profiles associated with specific phenotyopic traits |
| 07/24/2008 | CA2674552A1 Vaccine |
| 07/24/2008 | CA2673994A1 Lentivirus pseudotyped with influenza hemagglutinin and methods of use |
| 07/24/2008 | CA2673770A1 Human erythrovirus |
| 07/24/2008 | CA2673765A1 Enhanced cell-free synthesis of active proteins containing disulfide bonds |
| 07/24/2008 | CA2673361A1 Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants |
| 07/24/2008 | CA2672091A1 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | CA2667678A1 Toxin peptide therapeutic agents |
| 07/23/2008 | EP1947460A1 Method of measuring ptx3 with high sensitivity |
| 07/23/2008 | EP1947456A1 Method of confirming probe-loading position in nucleic acid array |
| 07/23/2008 | EP1947201A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/23/2008 | EP1947200A1 Method for quantitative determination of polyneucleotides in a mixture |
| 07/23/2008 | EP1947198A1 Maize plants characterised by quantitative trait loci (QTL) |
| 07/23/2008 | EP1947196A1 Method of amplifying multiple nucleic acid sequences for differentiation |
| 07/23/2008 | EP1947190A1 Process for production of succinic acid |
| 07/23/2008 | EP1947189A2 Method of vitamin production |
| 07/23/2008 | EP1947188A1 Methods of inducing and treating vascular disease |
| 07/23/2008 | EP1947187A1 Hybrid expression of neisserial proteins |
| 07/23/2008 | EP1947186A2 Application of glucose transport mutants for production of aromatic pathway compounds |
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947184A2 Delta-endotoxin genes and methods for their use |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947182A1 Fibroblast growth factor-23 molecules and uses thereof |
| 07/23/2008 | EP1947181A1 Mutant paramyxovirus and method for production thereof |
| 07/23/2008 | EP1947180A1 Transgenic silkworm capable of producing antibody and method for production thereof |
| 07/23/2008 | EP1947179A1 Novel aromatic acyl group transferase gene |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1947177A1 Novel endoribonuclease |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947172A2 Engineering of metabolic control |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1947117A2 Glycoprotein hormone superagonists |
| 07/23/2008 | EP1947116A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 07/23/2008 | EP1947115A2 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination, method of obtaining the cell line, method of producing the combination of glycoisoforms and methods for the treatment and preven |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946761A1 Carrier composition for nucleic acid transport |
| 07/23/2008 | EP1945808A2 Methods for detection of a nucleic acid by sequential amplification |
| 07/23/2008 | EP1945797A1 Hepatitis c virus ns2/3 activity assay |
| 07/23/2008 | EP1945790A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/23/2008 | EP1945782A2 Detection of intracellular enzyme complex |
| 07/23/2008 | EP1945781A1 Protein expression in rodent cells |
| 07/23/2008 | EP1945780A1 Rabies virus vector systems and compositions and methods thereof |
| 07/23/2008 | EP1945779A2 Improved aav vectors produced in insect cells |
| 07/23/2008 | EP1945778A2 Multi-plasmid system for the production of influenza virus |
| 07/23/2008 | EP1945777A1 Expression system incorporating a capsid promotor sequence as an enhancer of a cytomegalovirus promotor |
| 07/23/2008 | EP1945776A2 Dof (dna binding with one finger) sequences and methods of use |
| 07/23/2008 | EP1945775A2 Method for the production of gamma-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae |
| 07/23/2008 | EP1945774A1 Microprojectile bombardment transformation of brassica |
| 07/23/2008 | EP1945773A1 Recombinant expression of multiprotein complexes using polygenes |
| 07/23/2008 | EP1945772A1 Novel selection system |
| 07/23/2008 | EP1945771A1 Fusion proteins that bind effector lymphocytes and target cells |
| 07/23/2008 | EP1945770A1 A soybean root-preferred, nematode-inducible promoter and methods of use |
| 07/23/2008 | EP1945769A2 Glutathione-s-transferase gene from proposis juliflora confers abiotic stress tolerance in plants |
| 07/23/2008 | EP1945768A1 Modification of flavonoid biosynthesis in plants |
| 07/23/2008 | EP1945766A2 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone |
| 07/23/2008 | EP1945765A2 Structures of active guide rna molecules and method of selection |
| 07/23/2008 | EP1945764A1 Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue |
| 07/23/2008 | EP1945761A1 Arachnocampa luciferases |
| 07/23/2008 | EP1945755A2 Antibody profiles characteristic of tuberculosis state |
| 07/23/2008 | EP1945670A2 Therapeutic agent |
| 07/23/2008 | EP1945663A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 07/23/2008 | EP1945662A2 Methods for production of receptor and ligand isoforms |
| 07/23/2008 | EP1945661A1 Gpr 146 receptor |
| 07/23/2008 | EP1945270A2 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 07/23/2008 | EP1945266A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 07/23/2008 | EP1945258A2 Tdf-related compounds and analogs thereof |
| 07/23/2008 | EP1945255A2 Radiating element for radar array antenna |
| 07/23/2008 | EP1945248A2 Compositions and methods for the detection of trypanosoma cruzi infection |
| 07/23/2008 | EP1945247A1 Mucosal and systemic immunizations with alphavirus replicon particles |
| 07/23/2008 | EP1945043A2 Microorganism and process for the preparation of l-methionine |
| 07/23/2008 | EP1945022A2 Polynucleotides, dna constructs and methods for the alteration of plant cellulose content |
| 07/23/2008 | EP1945021A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 07/23/2008 | EP1766029A4 Transformation vectors |
| 07/23/2008 | EP1694837A4 Method |
| 07/23/2008 | EP1694692A4 Formulations and methods for denaturing proteins |
| 07/23/2008 | EP1644536A4 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 07/23/2008 | EP1573314B1 Transgenic mice expressing human cd20 |